Our Models Are Driving More Accurate Predictions for Clinical Trials

Clinical Trial Ranking Report:

The Prediction Engine for Clinical Research.

Every year, over $40 billion is spent on clinical trials that ultimately fail to achieve their endpoints. For BioPharma, investors, and researchers, these failures mean wasted resources, lost time, and missed opportunities to deliver life-changing therapies. 

The Clinical Trial Ranking Report (CTR Report) is transforming the clinical research landscape. 
Our advanced AI platform predicts trial failure with unmatched accuracy—helping you make smarter investment decisions, optimize resource allocation, and accelerate breakthrough discoveries. 

The Cost of Failure for Clinical Trials Is Staggering:

• 80% of clinical trials fail to meet enrollment timelines.
• Nearly 50% of Phase III trials fail, costing up to $1.3 billion per drug.
• Years of research and billions in capital are lost on Phase I & II trials that could have been predicted to fail before they even started.  

A custom CTR Report is your very first step for any Clinical Research Investment Decision.

Ready to see the future for clinical research assessment and prediction?

Are you ready to improve your clinical trial success rate by eliminating investment in bad targets? The CTR Report empowers you to make smarter, faster, and more confident decisions—reducing wasted money, time, and resources while accelerating breakthroughs. Connect with our team to learn more, request a sample report, or schedule a demo. 

    Join leading BioPharma teams, investors, and research organizations already leveraging CTR Reports to unlock smarter decisions, faster timelines, and more successful clinical trials.  

    Your information will be handled securely and routed directly to our team for prompt follow-up. 

    Clinical Trial Ranking Report
    The Prediction Engine for Clinical Research